Abstracts tagged "neurologic involvement and systemic lupus erythematosus (SLE)"

Abstract Number: 720 • 2018 ACR/ARHP Annual Meeting
Interkeukin-6 Level in Cerebrospinal Fluid As a Biomarker for Systemic Lupus Erythematosus Patients with Longitudinally Extensive Transverse Myelitis like Neuromyelitis Optica Spectrum Disease
Yasuhiro Hasegawa¹, Yoshiyuki Arinuma¹, Kazuma Ino¹, Takumi Muramatsu¹, Junichi Kondo¹, Yu Matsueda¹, Takayuki Hoshiyama¹, Toshihiro Tono¹, Tatsuhiko Wada¹, Tatsuo Nagai² and Sumiaki Tanaka¹, ¹Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan, ²Kitasato University, Department of Rheumatology and Infectious Diseases, Sagamihara, Japan
Background/Purpose: Demyelinating syndrome in NPSLE includes the wide range of lesions similar to multiple sclerosis (MS). Recently, the diagnostic criteria for neuromyelitis optica spectrum disease…
Abstract Number: 2834 • 2016 ACR/ARHP Annual Meeting
Utility of the Brain Perfusion Single Photon Emission Computed Tomography in Neuropsychiatric Manifestations of Systemic Lupus Erythematosus
Jorge Medina-Rosas¹, Murray Urowitz², Jiandong Su³, Dafna D Gladman⁴ and Zahi Touma², ¹Medicine, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada
Background/Purpose: The diagnosis of Neuropsychiatric Events (NPE) in SLE is challenging and it is mainly based on the physician judgment. Structural brain imaging has…
Abstract Number: 2663 • 2014 ACR/ARHP Annual Meeting
Sense of Smell, Anti-Ribosomal P Antibodies and Neuropsychiatric Manifestations in Systemic Lupus Erythematosus
Fernando Augusto Peres¹, Karina Oliveira Peliçari², Nailu A. Sinicato¹, Mariana Postal¹, Aline T. Lapa¹, Lilian Costallat³ and Simone Appenzeller⁴, ¹Medicine, State University of Campinas, Campinas, Brazil, ²State University of Campinas, Campinas, Brazil, ³Medicine, State University of Campinas, Campinas, United Kingdom, ⁴Medicine, Faculty of Medical Science, State University of Campinas Unicamp, São Paulo, Brazil
Background/Purpose Neuropsychiatric manifestations occur in 12-95% of SLE patients. Recent studies have demonstrated the high specificity of antiribosomal P antibodies for SLE. Antiribosomal P antibodies…
Abstract Number: 1397 • 2012 ACR/ARHP Annual Meeting
Risk Factors Associated with Early Central Nervous System Damage Detected Through Perfusion MRI in Patients with Systemic Lupus Erythematosus
Paola Tomietto¹, Federica Casagrande², Maja Ukmar², Luca Weis², Pia Morassi¹, Rita Moretti³, Gianni Biolo³, Carlo Giansante³ and Maria Assunta Cova², ¹Internal Medicine Department, AOU Ospedali Riuniti di Trieste, Trieste, Italy, ²Radiology Department, Radiology Department, University of Trieste, Trieste, Italy, ³Internal Medicine Department, Internal Medicine Department, University of Trieste, Trieste, Italy
Background/Purpose: Antiphospholipid antibodies (aPL), hypertension and accumulated damage (SLICC-DI) have been associated to the severity of cerebral MRI lesions and to cognitive deficits in SLE.…
Abstract Number: 622 • 2012 ACR/ARHP Annual Meeting
Headache in Systemic Lupus Erythematosus (SLE): Results From a Prospective, International, Inception Cohort Study
John G. Hanly¹ and Systemic Lupus International Collaborating Clincs², ¹Division of Rheumatology, Dalhousie University and Capital Health, Halifax, NS, Canada, ²(SLICC), Canada
Background/Purpose: Headache is common in SLE patients and in the general population. We examined the frequency, characteristics and attribution of headaches in a large, prospective,…
Abstract Number: 630 • 2012 ACR/ARHP Annual Meeting
Risk Factors Associated with Early Central Nervous System Damage Detected Through Diffusion Tensor Imaging (DTI) in Patients with Systemic Lupus Erythematosus
Paola Tomietto¹, Federica Casagrande², Maja Ukmar³, Luca Weis⁴, Pia Morassi⁵, Rita Moretti⁶, Gianni Biolo⁶, Carlo Giansante⁷ and Maria Assunta Cova⁸, ¹Internal Medicine Department, AOU Ospedali Riuniti, Trieste, Italy, ²Radiology department, University of Trieste, Trieste, Italy, ³Radiology Department, University of Trieste, Trieste, ⁴Radiology Department, University of Trieste, Trieste, Italy, ⁵Internal Medicine Department, AOU Ospedali Riuniti di Trieste, Trieste, Italy, ⁶Internal Medicine Department, University of Trieste, Trieste, Italy, ⁷Internal Medicine epartment, University of Trieste, Trieste, Italy, ⁸Department of Radiology, University of Trieste, Trieste, Italy
Background/Purpose: Antiphosholipid antibodies, SLICC-DI and some cardiovascular risk factors have been identified as risk factors for neuropsychiatric lupus (NPSLE). Diffusion tensor imaging (DTI) is an…
Abstract Number: 609 • 2012 ACR/ARHP Annual Meeting
Peripheral Neuropathy in Systemic Lupus Erythematosus
Amin Oomatia¹, Hong Fang², Michelle Petri² and Julius Birnbaum³, ¹School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom, ²Johns Hopkins University School of Medicine, Baltimore, MD, ³Rheumatology, Johns Hopkins University, Baltimore, MD
Background/Purpose: Whilst Neurological disorders are a common manifestation of systemic lupus erythematosus (SLE), peripheral neuropathies have received little attention. The literature consists mostly of small…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].